Atlas Trials

Romark Laboratories L.C.

29 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Romark Laboratories L.C.

RecordFirmDate
Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness (NCT05157269)Romark Laboratories L.C.2024-08-01
Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness (NCT05157243)Romark Laboratories L.C.2024-08-01
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection (NCT04489381)Romark Laboratories L.C.2020-08-19
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 (NCT04486313)Romark Laboratories L.C.2020-08-13
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection (NCT04359680)Romark Laboratories L.C.2020-05-13
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) (NCT04343248)Romark Laboratories L.C.2020-05-12
Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B (NCT03905655)Romark Laboratories L.C.2019-10-22
Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection (NCT03605862)Romark Laboratories L.C.2018-09-11

Track Romark Laboratories L.C. automatically

Every clearance here is in the API, with alerts when new ones post.